List of SBIR/STTR awards granted to Phasebio Pharmaceuticals, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Phasebio Pharmaceuticals, Inc. in February, 2018 for $297,765.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL140690-01 | Phase I | 297,765 | February 17, 2018 | |||||||
A SBIR Phase II contract was awarded to Phasebio Pharmaceuticals, Inc. in August, 2018 for $2,497,273.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44HL140690-02 | Phase II | 2,497,273 | August 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Phasebio Pharmaceuticals, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM077772-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Phasebio Pharmaceuticals, Inc. for $592,352.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM069024-02A1 | Phase II | 592,352 | ||||||||
A SBIR Phase I contract was awarded to Phasebio Pharmaceuticals, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM069024-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Phasebio Pharmaceuticals, Inc. for $100,000.0 USD from the National Science Foundation. | SBIR | 0320197 | Phase I | 100,000 |
